Search Browse Earnings

CITIUS ONCOLOGY, INC.

Nasdaq:CTOR

Pharmaceutical Preparations·CRANFORD, NJ

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CITIUS ONCOLOGY, INC. — SlamSEC

Revenue

—

Adj. EBITDA

—

Net Income

-$21.1M

FY 2025

EPS (Diluted)

-$0.31

FY 2025

Stock Price

$1.01

-5.6%

2026-03-06

52W Range

$0.55 – $6.19

P/E Ratio

-3.3x

Market Cap

$89.2M

Cash

$3.9M

FY 2025

Total Debt

—

Net Cash

$3.9M

Enterprise Value

$85.2M

Debt / EBITDA

—

EV / EBITDA

—

Employees

—

CEO

Mazur Leonard L

CFO

Bartushak Jaime